These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7735739)

  • 1. Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma.
    Suto Y; Shimatani Y
    Br J Radiol; 1995 Feb; 68(806):116-20. PubMed ID: 7735739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma.
    Suto Y; Shimatani Y; Kato T; Kamba M; Ohuchi Y; Kodama F; Kato T; Ohta Y
    Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course changes of contrast enhancement in iron colloid enhanced MRI in patients with hepatocellular carcinoma.
    Suto Y; Ametani M; Kamba M; Sugihara S
    Br J Radiol; 1996 Mar; 69(819):201-5. PubMed ID: 8800862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
    Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
    AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitin sulfate iron colloid-enhanced MR imaging in patients with hepatocellular carcinoma. Comparison with CT during arterial portography.
    Kamba M; Suto Y; Kato T
    Acta Radiol; 1994 Nov; 35(6):570-5. PubMed ID: 7946680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroitin sulfate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia.
    Suto Y; Kato T; Matsuo T; Kamba M; Shimatani Y; Ohuchi Y; Nakamura K; Ohta Y
    Acta Radiol; 1993 May; 34(3):226-9. PubMed ID: 8387803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
    Peterson MS; Baron RL; Murakami T
    Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
    Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
    AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimum conditions for iron colloid enhanced fast spin echo imaging in hepatocellular carcinoma.
    Sugihara S; Suto Y; Yoshida K
    Br J Radiol; 1997 Aug; 70(836):791-7. PubMed ID: 9486042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between chondroitin sulfate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma.
    Suto Y; Kodama F; Kamba M; Ohta Y
    Acta Radiol; 1995 Jan; 36(1):102-5. PubMed ID: 7833161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat.
    Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J
    Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of chondroitin sulfate iron colloid as a liver specific MR contrast agent.
    Hussain MZ; Ohtomo K; Kachi K; Uchiyama G; Itai Y
    Radiat Med; 1994; 12(1):1-5. PubMed ID: 8016397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging in the detection of focal liver lesions: comparison of dynamic contrast-enhanced TurboFLASH and T2 weighted spin echo images.
    Ward J; Baudouin CJ; Ridgway JP; Robinson PJ
    Br J Radiol; 1995 May; 68(809):463-70. PubMed ID: 7788230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.
    Murakami T; Nakamura H; Tsuda K; Nakanishi K; Hori S; Tomoda K; Mitani T; Kozuka T; Monden M; Wakasa K
    AJR Am J Roentgenol; 1993 Feb; 160(2):295-9. PubMed ID: 8380948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small hepatocellular carcinoma on magnetic resonance imaging. Relation of signal intensity to angiographic and clinicopathologic findings.
    Honda H; Kaneko K; Maeda T; Kuroiwa T; Fukuya T; Yoshimitsu K; Irie H; Aibe H; Takenaka K; Masuda K
    Invest Radiol; 1997 Mar; 32(3):161-8. PubMed ID: 9055129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging.
    Lencioni R; Mascalchi M; Caramella D; Bartolozzi C
    Abdom Imaging; 1996; 21(1):41-8. PubMed ID: 8672971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.